322 related articles for article (PubMed ID: 25311350)
1. Decade in review-cancer immunotherapy: entering the mainstream of cancer treatment.
Rosenberg SA
Nat Rev Clin Oncol; 2014 Nov; 11(11):630-2. PubMed ID: 25311350
[No Abstract] [Full Text] [Related]
2. Immunotherapy of cancer: a critical review.
Lutz D
Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):118-29. PubMed ID: 6343261
[TBL] [Abstract][Full Text] [Related]
3. [Immunotherapy of cancer].
Lascano FD; Mazzei JA; Estevez ME
Prensa Med Argent; 1971 Mar; 58(2):75-91. PubMed ID: 4103879
[No Abstract] [Full Text] [Related]
4. Current aspects of immunotherapy in cancer.
Langenbecks Arch Chir; 1981; 354(1):1-17. PubMed ID: 7253782
[No Abstract] [Full Text] [Related]
5. [Immunotherapy of hemato-oncologic diseases].
Winkler U; Bohlen H; Schirrmacher V; Schlimok G; Voliotis D; Brach M; Niederle N; Tesch H; Diehl V; Engert A
Med Klin (Munich); 1996 Apr; 91(4):226-33. PubMed ID: 8692109
[No Abstract] [Full Text] [Related]
6. [The immunotherapeutic approaches to the management of leukemia and neoplasms].
Leu TP
Zhonghua Yi Xue Za Zhi; 1974 May; 5():310-4. PubMed ID: 4211699
[No Abstract] [Full Text] [Related]
7. [Methods of influencing immunity in leukemia].
Abdulkadyrov KM; Ushakova EA; Shcherbakova EG; Samuskevich IG; Popova TI
Gematol Transfuziol; 1984 Nov; 29(11):8-11. PubMed ID: 6397397
[No Abstract] [Full Text] [Related]
8. [Problems of the immunotherapy of malignant neoplasma].
Trapeznikov NN; Iavorskiĭ VV
Klin Med (Mosk); 1975 May; 52(5):15-22. PubMed ID: 1094178
[No Abstract] [Full Text] [Related]
9. Current status of immunotherapy of human cancers: leukaemias, lymphomas, solid tumours.
Mathé G
Drugs; 1974; 8(6):411-6. PubMed ID: 4616827
[No Abstract] [Full Text] [Related]
10. Application of T cell immunotherapy for human viral and malignant diseases.
Riddell SR; Warren EH; Lewinsohn D; Mutimer H; Topp M; Cooper L; de Fries R; Greenberg PD
Ernst Schering Res Found Workshop; 2000; (30):53-73. PubMed ID: 10943316
[No Abstract] [Full Text] [Related]
11. Cancer active immunotherapy. Immunoprophylaxis and immunorestoration. An introduction.
Mathé G
Recent Results Cancer Res; 1976; 55():1-402. PubMed ID: 1087040
[No Abstract] [Full Text] [Related]
12. Cancer vaccines and immunotherapies: emerging perspectives.
Henderson RA; Mossman S; Nairn N; Cheever MA
Vaccine; 2005 Mar; 23(17-18):2359-62. PubMed ID: 15755628
[TBL] [Abstract][Full Text] [Related]
13. Vaccination and malignant disease: promising therapeutic approach.
McKechnie A; Robins RA; Eremin O
Surgeon; 2005 Jun; 3(3):224-33. PubMed ID: 16076009
[TBL] [Abstract][Full Text] [Related]
14. Advances in cancer immunotherapy.
Ockert D; Schmitz M; Hampl M; Rieber EP
Immunol Today; 1999 Feb; 20(2):63-5. PubMed ID: 10098323
[No Abstract] [Full Text] [Related]
15. New developments in immunotherapy for pediatric leukemia.
Foster JB; Maude SL
Curr Opin Pediatr; 2018 Feb; 30(1):25-29. PubMed ID: 29176353
[TBL] [Abstract][Full Text] [Related]
16. Next-generation leukemia immunotherapy.
Vincent K; Roy DC; Perreault C
Blood; 2011 Sep; 118(11):2951-9. PubMed ID: 21734234
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic immune replacement as cancer immunotherapy.
Chakrabarti S; Childs R
Expert Opin Biol Ther; 2003 Oct; 3(7):1051-60. PubMed ID: 14519070
[TBL] [Abstract][Full Text] [Related]
18. A new era for cancer immunotherapy based on the genes that encode cancer antigens.
Rosenberg SA
Immunity; 1999 Mar; 10(3):281-7. PubMed ID: 10204484
[No Abstract] [Full Text] [Related]
19. Immunology and colonic cancer: cancer immunotherapy results in leukemias--experimental and clinical approaches to the treatment of solid tumors.
Mathé G; Thompson RB
Dis Colon Rectum; 1973; 16(5):341-57. PubMed ID: 4590448
[No Abstract] [Full Text] [Related]
20. Cancer vaccines: pessimism in check.
Timmerman JM; Levy R
Nat Med; 2004 Dec; 10(12):1279; author reply 1279-80. PubMed ID: 15682512
[No Abstract] [Full Text] [Related]
[Next] [New Search]
